← SynDRA
PALOVAROTENE
SynDRA canonical compound SYN0031521 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | RARG |
|---|
| Mechanism of action | retinoid receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- RARG AGONIST
- Retinoic acid receptor gamma agonist
- retinoid receptor agonist
ATC classes
- M09A · OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
Cross-references
Synonyms
- RO3300074
- CLM-001
- IPN60120
- sohonos
- Palovaroteno
- R-667
- IPN-60120
- RG-667
- RO-3300074
- Sohonos
- Retinoid receptor agonist, Roche
- Ro-3300074
- Ro-330074
- Ro 3300074
- palovaroteno
- R 667
- palovarotenum
- RefChem:58843
- DTXCID601509964
- R667
- Palovarotene [USAN]
- Palovarotene [USAN:INN]
- UNII-28K6I5M16G
- Sohonos (TN)
- Palovarotene(R 667)
- Palovarotene(R 667)?
- PALOVAROTENE [INN]
- PALOVAROTENE [JAN]
- PALOVAROTENE [WHO-DD]
- GTPL8276
- orb1302775
- Palovarotene (JAN/USAN/INN)
- SCHEMBL4668028
- SCHEMBL29354070
- CHEBI:188559
- YTFHCXIPDIHOIA-DHZHZOJOSA-N
- GLXC-90248
- EX-A3101
Look up PALOVAROTENE in the interactive SynDRA portal →